Recent Analyst Forecasts and Stock Ratings
Design Therapeutics, Inc. FAQ's
Design Therapeutics, Inc. has been rated by research analysts at Piper Sandler, RBC Capital, Goldman Sachs in the past 90 days.
Design Therapeutics, Inc. has been rated by research analysts at Piper Sandler, RBC Capital, Goldman Sachs in the past 90 days.